Stock LSB LAKESHORE BIOPHARMA CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Consensus LakeShore Biopharma Co., Ltd

Equities

LSB

KYG9845F1090

Market Closed - Nasdaq
Other stock markets
 21:30:00 24/06/2024 BST 		5-day change 1st Jan Change
0.6545 USD +9.08% Intraday chart for LakeShore Biopharma Co., Ltd -5.16% +28.08%
06-18 LakeShore Biopharma Co., Ltd Announces Chief Financial Officer Changes CI
06-18 LakeShore Biopharma Co., Ltd Announces Resignation of Zengjun Xu as Director CI

Evolution of the average Target Price on LakeShore Biopharma Co., Ltd

Price target over the last 5 years

History of analyst recommendation changes

3f784f.xfa0ChQckV4bytQjzKeSKoHxj0DUrfuRfz46HTIkolk.pJH9QiQsqA8ipb9rts34ZPeJwgeV3ojiC3ALVlp9xg6Cpv5zeErdKUT4tw~36b888d54627d3ea62d5b010cef75455

Analyst Recommendations on LakeShore Biopharma Co., Ltd

Noble Capital Initiates YS Biopharma With Outperform Rating, $5.25 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.751 CNY
Average target price
29.98 CNY
Spread / Average Target
+531.08%
High Price Target
37.51 CNY
Spread / Highest target
+689.48%
Low Price Target
22.46 CNY
Spread / Lowest Target
+372.68%

Consensus detail

Consensus revision (last 18 months)

Analysts covering LakeShore Biopharma Co., Ltd

Noble Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LSB Stock
  4. Consensus LakeShore Biopharma Co., Ltd